Johnson & Johnson (JNJ) Stock Forecast & Price Predictions for 2025, 2026, 2027–2030, 2040 and Beyond | LiteFinance

2025.09.01 2025.09.01
Johnson & Johnson Stock Forecast & Price Predictions for 2025, 2026, 2027–2030 and Beyond

Jana Kanehttps://www.litefinance.org/blog/authors/jana-kane/

The Johnson & Johnson (JNJ) stock has long been a compelling asset thanks to the company’s stability, reliability, and upside potential. Despite short-term corrections and market volatility, J&J continues to hold a solid footing across the pharmaceutical, consumer, and healthcare sectors.

Fundamental and technical analysis will allow investors and traders to make more informed decisions regarding buying or selling stocks. Besides, this article reviews expert forecasts for the JNJ stock and provides a trading plan.

Major Takeaways

• The current price of JNJ is $177.07 as of 02.09.2025.
• The JNJ price reached its all-time high of $186.01 on 25.04.2022. The stock’s all-time low of $0.78 was recorded on 26.05.1970.
• The company is actively investing in healthcare, personalized medicine, and biotechnology.
• JNJ pays dividends consistently and regularly increases their amount.
• Johnson & Johnson’s market capitalization exceeds $426 billion, reflecting high investor confidence.
• According to technical analysis, in 2025, the asset will likely trade in a downward channel between $185.00 and $146.00.
• According to analysts, the price of JNJ shares may rise to $190.00–$200.00 by 2027.

JNJ Real-Time Market Status

The JNJ stock is trading at $177.07 as of 02.09.2025.

To assess the Johnson & Johnson (JNJ) stock’s upside potential, investors should monitor its market capitalization, the price change over the year, and the P/E ratio. Dividend policy and EBITDA are also crucial indicators, reflecting the company’s financial strength and management efficiency in the long term.

JNJ Stock Price Forecast for 2025 Based on Technical Analysis

According to technical analysis, in September 2025, JNJ will trade in the range of $175.06–$169.07, exhibiting moderate volatility. In late October and early November, the price may increase to the $181.35 area, exceeding the swing high. By the end of December, JNJ may return to the level of $169.00, confirming the onset of a short-term correction.

The SMA50 moving average is trending above the SMA200, reflecting the stability of the medium-term upward momentum, which is capable of sustaining growth in the coming weeks. The RSI is near 63, suggesting increased bullish momentum, but its proximity to the overbought zone explains the possible weakening of momentum at the end of the year. The MACD indicator remains in positive territory, setting the stage for a gradual recovery and the formation of a more stable trend with tempered volatility.

Below are the forecast values for Johnson & Johnson (#JNJ) share prices for the next 12 months.

Long-Term Trading Plan for #JNJ for 2025

In 2025, a trading strategy for JNJ shares suggests opening trades near the key support and resistance levels. The potential entry point is located in the $169.00–$170.00 area, where the correction is expected to end in December. If the price settles above $175.00, long positions can be opened with the target of $181.00. A breakout of this mark will allow the JNJ price to strengthen next year.

The SMA50, positioned above the SMA200, lays the foundation for a medium-term bullish scenario, confirming that long positions can be kept open. The RSI around 63 indicates possible overheated areas, so partially locking in profits near $181.00 seems reasonable. The MACD remains in the positive area, supporting expectations of a recovery after December’s decline.

Analysts’ JNJ Shares Price Projections for 2025

JNJ price forecasts for 2025 vary significantly. Some analysts expect moderate movement within a sideways range, others anticipate a gradual decline, while some point to a possible price increase by the end of the year.

CoinCodex

Price range in 2025: $162.14–$178.30 (as of 31.08.2025).

CoinCodex suggests that in 2025, JNJ quotes will trade within a narrow range, with no significant fluctuations expected. The stock will likely remain close to its average yearly values, occasionally approaching the upper boundary.

StockScan

Price range in 2025: $146.43–$168.21 (as of 31.08.2025).

According to StockScan, JNJ quotes will face pressure in 2025, displaying muted trading within a narrow range in the fall. The price may decline to new swing lows in December.

WalletInvestor

Price range in 2025: $168.95–$185.00 (as of 31.08.2025).

WalletInvestor analysts assume that in early fall, JNJ prices may reach the upper boundary of the trading range at around $185.00. However, by December, the price is expected to return to the lower boundary at around $175.00.

Analysts’ JNJ Shares Price Projections for 2026

Forecasts for 2026 appear more certain, with some analysts anticipating moderate growth, while others foreseeing short-lived corrections. The impact of market-wide factors and seasonality is also reflected in the forecasts.

Note: The price ranges below reflect the expected volatility of the asset over a year. The minimum and maximum prices may not be displayed in the tables.

CoinCodex

Price range in 2026: $166.53–$196.81 (as of 31.08.2025).

Analysts at CoinCodex predict that Johnson & Johnson share prices will gradually rise in the first half of 2026, peaking above $196.00 in April. In the second half of the year, fluctuations and partial pullbacks are possible, but the range will remain wide.

StockScan

Price range in 2026: $150.27–$192.87 (as of 31.08.2025).

StockScan‘s forecast suggests that the asset may be under pressure. In January, the JNJ stock will drop to $150.00. A recovery is expected in the spring, and by the fall, the quotes may soar above $186.00–$192.00. At the end of the year, a moderate pullback is possible.

WalletInvestor

Price range in 2026: $169.56–$175.30 (as of 31.08.2025).

WalletInvestor predicts that the company’s shares will trade in a narrow range of $170.00–$175.00 in 2026, with subdued bullish momentum in the spring and summer and a slight decline towards the end of the year.

Analysts’ JNJ Shares Price Projections for 2027

Forecasts for 2027 also point to mixed trends. Some analysts predict growth with new swing highs, while others expect corrections and fluctuations within a narrow range.

CoinCodex

Price range in 2027: $155.74–$191.01 (as of 31.08.2025).

Analysts at CoinCodex predict that JNJ shares will show choppy trading in 2027. Between January and July, the price may rise to the upper boundary of the predicted range, but in the fall, a decline to the range of $155.00–$163.00 is forecast. At the end of the year, JNJ quotes are likely to remain at their average values, without any sharp fluctuations.

StockScan

Price range in 2027: $168.79–$199.80 (as of 31.08.2025).

StockScan‘s forecast indicates that JNJ’s price will rise above $190.00 by summer 2027. In August–September, quotes will exceed their yearly high, hitting the 199.00 mark. By the end of the year, minor pullbacks are possible, but the overall trend will remain bullish.

WalletInvestor

Price range in 2027: $164.21–$169.94 (as of 31.08.2025).

WalletInvestor analysts offer a conservative outlook, predicting that JNJ quotes will move within a tight range in 2027. The price may fluctuate near $165.00–$169.00 for most of the year, exhibiting no substantial fluctuations.

Analysts’ JNJ Shares Price Projections for 2028

Analysts agree that Johnson&Johnson will experience a gradual weakening in 2028. The only difference among the presented assessments lies in the pace of decline. Some analysts expect the drop to be smooth, while others anticipate that it will be accompanied by elevated volatility and short-term spikes.

CoinCodex

Price range in 2028: $152.92–$177.71 (as of 31.08.2025).

According to CoinCodex, JNJ will open above $170.00 in 2028, but a sharp decline to $153.00 is possible in the spring. A recovery is forecast for the summer, but by December, prices will return to yearly lows.

StockScan

Price range in 2028: $163.42–$194.29 (as of 31.08.2025).

StockScan also predicts a downward trend. In spring 2028, there may be a surge to $194.00, but by summer and fall, JNJ quotes will likely fall to a lower range of $164.00–$170.00 and recover slightly by the end of the year.

WalletInvestor

Price range in 2028: $158.88–$164.59 (as of 31.08.2025).

WalletInvestor gives the most cautious outlook for 2028. JNJ quotes will likely decline within a narrow range of $159.00–$164.00, with no signs of growth to new yearly highs.

Analysts’ JNJ Shares Price Projections for 2029

In their forecasts for 2029, analysts are unanimous in their expectation of a slowdown in JNJ prices. While some anticipate short-lived price spurts, the overall backdrop remains bearish, with prices gradually shifting to a lower trading range.

CoinCodex

Price range in 2029: $151.57–$190.66 (as of 31.08.2025).

CoinCodex predicts that in 2029, the JNJ stock will start with a drop to around $151.00, but growth to $190.00 is possible in the summer. At the end of the year, the price is likely to remain above the January levels, mirroring a gradual recovery.

StockScan

Price range in 2029: $156.68–$189.37 (as of 31.08.2025).

According to StockScan estimates, prices will remain around $180.00–$189.00 at the beginning of 2029, but a gradual decline is forecast in spring. By the end of the year, the price will likely slide to around $160.00–$166.00, facing sustained downward pressure.

WalletInvestor

Price range in 2029: $153.54–$159.24 (as of 31.08.2025).

WalletInvestor predicts a narrow price range for JNJ with no increase expected. Throughout the year, quotes will gradually decline from $159.00 to $153.00–$154.00.

Analysts’ JNJ Shares Price Projections for 2030

For 2030, analysts offer a wide range of views on the JNJ stock’s performance. Some anticipate a gradual strengthening and sustained demand for the company’s shares, while others foresee a decline due to downward pressure. There are also more optimistic scenarios, which predict strong growth and new highs. This discrepancy in forecasts underscores the inherent uncertainty associated with such a distant forecast period, emphasizing the importance of approaching the data as a reference rather than precise predictions.

CoinCodex

Price range in 2030: $176.24–$208.27 (as of 31.08.2025).

According to CoinCodex‘s forecast, the JNJ stock may post gains in March and April, and the price will exceed $200.00. However, drawdowns are projected in the summer, but in December, JNJ quotes may remain near the upper border of the trading channel, following a bullish scenario.

StockScan

Price range in 2030: $134.44–$179.51 (as of 31.08.2025).

StockScan anticipates that the asset will face high volatility in 2030. A decline is projected in the spring, followed by a partial recovery in the summer. The price will likely reach new higher highs, reflecting attempts to hold ground despite continued pressure. In the fall and winter, the share price may drop to new lows, while short-term spikes cannot be ruled out.

CoinPriceForecast

Price range in 2030: $246.00–$263.00 (as of 31.08.2025).

CoinPriceForecast predicts steady growth for the JNJ stock in 2030. In the middle of the year, quotes may reach $246.00, and by the end of the year, they may rise to $263.00, mirroring a sustained upward trend.

Analysts’ JNJ Shares Price Projections until 2050

Analysts have different assessments of JNJ’s long-term prospects. Some analysts predict a gradual strengthening, while others point to the likelihood of declines. At the same time, some analytical agencies offer extremely optimistic scenarios with new all-time highs. Despite the difference in approaches, the consensus forecast is bullish.

According to CoinCodex, by 2040, the average price of JNJ could be around $197.00, and by 2050, it may approach $262.00. The forecast reflects a smooth movement with moderate volatility and a gradual upward trajectory.

StockScan suggests a more cautious scenario. In 2035, the average price is estimated at $179.00, by 2040, it will climb to around $203.00, and by 2050, JNJ will reach $240.00. This forecast reflects a gradual strengthening without sharp spikes or drops, based on the fundamental sustainability of the JNJ stock.

CoinPriceForecast gives the most optimistic estimate. By 2035, the average price may exceed $390.00. This scenario offers a significantly higher price than other platforms expect and reflects an aggressive bullish bias.

All three platforms agree that JNJ’s long-term trajectory will be upward, but the magnitude of the movement varies greatly from moderate growth to aggressive breakthroughs to new highs. This discrepancy reflects the uncertainty of long-term forecasts but confirms that the primary trend will be bullish.

Market Sentiment for JNJ (Johnson & Johnson) on Social Media

Social media sentiment can be seen as an additional tool for assessing the general opinion of market participants about future price movements. Discussions and posts on social media platforms often shape the background that can influence short-term fluctuations. The more actively an asset is discussed, the more noticeable the reaction on the chart may be.

For traders, media sentiment is a powerful addition to technical analysis. A change in the prevailing tone in communities or an increase in the number of mentions sometimes coincides with the beginning of volatile phases. By using media sentiment in conjunction with key levels and indicators, you can better assess the likelihood of an acceleration in price movement and make trading decisions in advance.

For example, user @equipredict notes on social network X (formerly Twitter) that Johnson & Johnson shares are likely to continue their steady growth until the end of 2025. The chart shows that the uptrend will likely continue, which indicates long-term appetite for the trading instrument. This scenario points to a sustainable upward trend.

Meanwhile, user @lcparodi, on the contrary, emphasizes that the current growth may be short-term, considering the Elliott wave structure. The analysis points to the likelihood of an imminent reversal and subsequent decline.

Overall, sentiment on social media regarding JNJ remains mixed. Some users expect steady growth and a long-term trend, while others suggest that the current rally is short-lived and that a reversal is likely. This divergence of opinion creates a neutral backdrop and indicates increased caution among market participants.

JNJ Price History

Johnson & Johnson (JNJ) reached its all-time high of $186.01 on 25.04.2022.

The lowest price of Johnson & Johnson (JNJ) was recorded on 26.05.1970 when the stock declined to $0.78.

It is important to evaluate historical data in order to make our forecasts as accurate as possible. Below is a chart of JNJ over the last ten years.

Johnson & Johnson (JNJ) shares have been traded on the stock exchange since 1944 and have steadily increased in value thanks to the company’s innovations in pharmaceuticals and healthcare. Moreover, the price was influenced by successful clinical trials of new drugs and major acquisitions expanding the company’s product portfolio.

However, JNJ’s history has also been marked by sharp falls. For instance, in December 2018, the stock plunged by 10% due to the scandal surrounding asbestos in baby powder, which triggered a wave of lawsuits. In 2020, the COVID-19 pandemic caused a 20% drop amid global uncertainty. Despite these challenges, the company has quickly regained ground through successful vaccine development.

JNJ Shares Fundamental Analysis

Fundamental analysis of Johnson & Johnson (JNJ) helps determine factors that affect the stock price.

What Factors Affect the JNJ stock?

Johnson & Johnson’s stock price is influenced by the following factors:

• Financial reports: quarterly and annual reports reflecting profit, revenue, and debt load.
• Dividend policy of the company.
• Regulatory changes: approval or prohibition of new drugs, changes in legal requirements.
• Litigation: results of major lawsuits, such as the talcum powder or opioid cases.
• Competition: successes of competitors that may affect investor preferences.
• Macroeconomic conditions: changes in interest rates, inflation, and economic growth.
• Strategic acquisitions: purchasing other companies and integrating new products.

More Facts About JNJ

The Johnson & Johnson (JNJ) company was founded in 1886 in the US by brothers Robert, James, and Edward Johnson. Initially, the company specialized in the production of sterile medical dressings. Today, JNJ is one of the world’s largest corporations in the healthcare industry.

The company operates across three main segments: pharmaceuticals, medical devices, and consumer products. Its popular products include Band-Aid bandages, Tylenol medications, and personal care products from Neutrogena and Johnson’s Baby.

The JNJ stock is included in the Dow Jones Index and is considered one of the most stable and attractive assets for long-term investors due to its regular dividend payouts and strong financial position.

Advantages and Disadvantages of Investing in JNJ

Investing in Johnson & Johnson (JNJ) stocks has a number of advantages. However, there are also certain risks.

Advantages

• Consistent dividend payouts and the company’s dividend aristocrat status make the stock appealing to long-term investors seeking a steady income.
• A diversified business structure covering the pharmaceutical, consumer products, and medical devices markets mitigates the risks of significant price fluctuations.
• JNJ’s worldwide brand recognition, along with its established reputation for reliability and top-notch quality, strengthens the trust of consumers and investors.
• The company is actively investing in innovative medical developments and biotechnology, offering new prospects for long-term growth.
• Rapid expansion into Asian and Latin American markets, where the burgeoning middle class is fuelling demand for products, boosting the company’s profits.

Disadvantages

• The company faces lawsuits related to product safety, negatively affecting its reputation.
• The intense competition in the market demands ongoing investment in marketing and research to uphold the company’s position.
• Changes in healthcare regulation, new legislative initiatives, and government policies may adversely affect the company’s sales and earnings.
• Inflationary pressures and rising operating costs are eroding margins in the consumer goods segment.
• High expenses and unpredictable outcomes of clinical trials for new medicines pose additional risks to the company’s financial performance.

Considering the pros and cons, the JNJ stock remains a promising investment, particularly for conservative investors.

How We Make Forecasts

We use a comprehensive approach to forecast JNJ’s future stock price.

Short-term forecasts are based on technical analysis: current market trends, volatility, as well as support and resistance levels are studied.

Medium-term forecasts rely on fundamental analysis involving the company’s financial reports, new products, and market trends.

Long-term forecasts take into account global macroeconomic trends, the company’s strategy, its market position, and the general state of the industry. Besides, the opinions of leading analysts and market sentiment are considered.

Conclusion: Is JNJ a Good Investment?

Johnson & Johnson shares represent an asset with a strong foothold in the market and sustainable long-term price trends. Analysts’ forecasts vary, but most predictions still point to a smooth strengthening with periods of correction. The JNJ stock features moderate growth potential and low risk compared to more volatile assets. However, trading decisions should be made considering your long-term goals and risk tolerance.

Price chart of JNJ in real time mode